Biopharmaceutical leader in the development of treatments for rare diseases
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.
Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
Education about the value of innovative new medicines.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX